Kotak Equities initiates coverage on JB Chemicals with a target price of Rs 2,025
Calling it a ‘potent fusion’, domestic brokerage firm Kotak Institutional Equities (KIE) initiated coverage on JB Chemicals and Pharmaceuticals (JBCP) as it sees an upside growth potential of 12.4% in the stock. KIE has a ‘buy’ call on the stock with a target price of Rs 2,025. The domestic brokerage believes that JBCP offers a … Read more
